From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

Researchers at Carnegie Mellon University have developed a groundbreaking lens technology that enables a camera to focus on ...

The depth-defying lens can focus on multiple objects at different distances.

Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a ...

A tiny device can control laser light very precisely while using much less power, making it possible to build bigger and ...

As of Monday, December 29, Aligos Therapeutics, Inc.’s ALGS share price has dipped by 5.24%, which has investors questioning ...

A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

This move represented a sharp increase in price on volume nearly 3x the average daily trading volume, indicating robust ...

Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...